Apologies, turns out the text I cited was from risk management statement in the 2020 report, not 2021. https://assets-au-01.kc-usercontent.com/bca3e5d5-83bd-02bf-1c27-acb036630e5b/8075f4c8-b03f-4f1d-b8c2-0e21f571bd3d/3916-a2-Milk-AR20-WEB-pages-1.pdf
It's interesting that there is slight variation in wording from one year to the next, as they definitely mentioned the grace period in 2020 then removed this in 2021. Not sure if it is meaningful or not. Clearly at some point the company regarded the expiry as potentially subject to the grace period. Possibly that information is outdated or they've had further advice, but it still remains listed as a risk so should probably be treated as such.
FDA Approval, page-198
-
- There are more pages in this discussion • 121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.80 |
Change
-0.100(1.69%) |
Mkt cap ! $4.225B | |||
| Open | High | Low | Value | Volume |
| $5.87 | $5.91 | $5.79 | $5.343M | 913.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2184 | $5.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.81 | 7180 | 15 |
View Market Depth
| Last trade - 15.58pm 23/08/2024 (20 minute delay) ? |
| A2M (ASX) Chart |